This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Carnitine palmityltransferase deficiency

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

This is a deficiency of carnitine palmityltransferase, the enzyme which controls the entry of long-chain fatty acids into the mitochondria.

The enzyme deficiency can be confirmed via biochemical assay performed on a muscle sample (or peripheral blood sample).

Treatment is by avoidance of precipitants. No specific treatment is, as yet, available.

Prognosis is good if the myoglobulinuria is not so severe as to cause renal failure and as long as precipitants are avoided.


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page